Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 78
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-28160390

ABSTRACT

BACKGROUND: Angiotensin II (Ang II), the main peptide of the renin-angiotensin system (RAS), has been suggested to be involved in inflammatory bowel diseases. Since RAS has emerged as gut motility regulator, and dysmotility is associated with intestinal inflammation, our objective was to investigate in rat 2,4-dinitrobenzenesulfonic acid (DNBS)-induced colitis the functionality of RAS and its contribution to colonic motor alterations. METHODS: The effects of Ang II on the longitudinal colonic muscular contractility of control and DNBS-treated rats were characterized in vitro. Transcripts encoding for Ang II receptors were investigated by RT-PCR. KEY RESULTS: Inflamed preparations showed a longitudinal muscle marked hypocontractility. Angiotensin II caused contractile effects in both preparations, but the responses in DNBS preparations were reduced compared to controls. In both preparations, Losartan, AT1 receptor antagonist, reduced Ang II effects. PD123319, AT2 receptor antagonist, enhanced Ang II responses only in DNBS rats, as well as Nω -Nitro-L-arginine (L-NNA), nitric oxide (NO) synthase inhibitor, or tetrodotoxin (TTX), neural toxin. The co-administration of PD123319 and TTX or L-NNA produced no additive effects. PD123319 per se improved colonic contractility in inflamed tissues. The effect was reduced in the presence of L-NNA or TTX. All Ang II receptor subtypes were expressed in both preparations. CONCLUSIONS & INFERENCES: AT1 receptors mediate Ang II contractile responses in rat colon. During inflammation a recruitment of Ang II AT2 receptors would counteract AT1 -contractile activity. A tonic activation of AT2 receptors would contribute to the general reduction in muscle contractility during experimental inflammation. A role for enteric neurons and NO is also suggested.


Subject(s)
Colitis/physiopathology , Colon/physiopathology , Gastrointestinal Motility , Receptor, Angiotensin, Type 2/physiology , Angiotensin II/administration & dosage , Angiotensin II/physiology , Animals , Colitis/chemically induced , Colon/metabolism , Dinitrofluorobenzene/administration & dosage , Dinitrofluorobenzene/analogs & derivatives , Male , Muscle Contraction , Muscle, Smooth/physiopathology , Rats, Wistar , Receptor, Angiotensin, Type 2/agonists , Receptor, Angiotensin, Type 2/metabolism , Renin-Angiotensin System
2.
Acta Physiol (Oxf) ; 215(1): 37-45, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26052867

ABSTRACT

AIM: To analyse the effects of angiotensin II (Ang II) on the contractility of human sigmoid colon, and to characterize the subtype(s) of receptor(s) involved and the related action mechanism. METHODS: The contractility of sigmoid colon circular muscle strips was recorded isometrically. RT-PCR and immunohistochemistry were used to reveal the eventual existence of a local renin-angiotensin system (RAS) and the distribution of Ang II receptors. RESULTS: Transcripts encoding for the Ang II type 1 (AT1 ) and the Ang II type 2 (AT2 ) receptor subtypes and for the angiotensin-converting enzyme in the whole-thickness muscular wall were observed. Ang II caused a concentration-dependent contractile response, which is antagonized by losartan, AT1 receptor antagonist, but not by PD123319, AT2 receptor antagonist. The joint application of losartan and PD123319 did not produce any additive effect. The contractile response to Ang II was partially reduced by tetrodotoxin, Na(+) voltage-gated neural channel blocker, and to some extent by SR48968, tachykinin NK2 receptor antagonist. However, hexamethonium, nicotinic receptor antagonist, atropine, cholinergic muscarinic receptor antagonist and SR140333, tachykinin NK1 receptor antagonist, were ineffective. Immunohistochemical analysis showed that AT1 receptors were expressed on the smooth muscle layers and myenteric plexus. CONCLUSION: Ang II positively modulates the spontaneous contractile activity of human sigmoid colon via activation of post-junctional and pre-junctional AT1 receptors, the latter located on the enteric nerves that modulate the release of tachykinins. The presence of the components of RAS in the human colon suggests that Ang II can be also locally generated to control colonic motility.


Subject(s)
Angiotensin II/pharmacology , Colon, Sigmoid/drug effects , Colon, Sigmoid/metabolism , Receptor, Angiotensin, Type 1/metabolism , Receptor, Angiotensin, Type 2/metabolism , Renin-Angiotensin System/drug effects , Aged , Aged, 80 and over , Female , Humans , Imidazoles/pharmacology , Male , Middle Aged , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Peptidyl-Dipeptidase A/metabolism , Pyridines/pharmacology , Renin-Angiotensin System/physiology
3.
Acta Physiol (Oxf) ; 207(2): 337-45, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23170805

ABSTRACT

AIM: This study investigates whether a local renin-angiotensin system (RAS) exists in mouse colon and whether angiotensin II (Ang II) may play a role in the regulation of the contractile activity. METHODS: Isometric recordings were performed in vitro on the longitudinal muscle of mouse proximal and distal colon. Transcripts encoding for RAS components were investigated by RT-PCR. RESULTS: Ang II caused, in both preparations, a concentration-dependent contractile effect, antagonized by losartan, AT(1) receptor antagonist, but not by PD123319, AT(2) receptor antagonist. The combination of losartan plus PD123319 caused no change on the Ang II-induced contraction than losartan alone. Tetrodotoxin, neural blocker, reduced the contractile response to Ang II in the proximal colon, whilst the response was abolished in the distal colon. In both preparations, atropine, muscarinic receptor antagonist, or SR140333, NK(1) receptor antagonist, reduced the Ang II responses. Ondansetron, 5-HT(3) receptor antagonist, SR48968, NK(2) receptor antagonist, or hexamethonium, nicotinic receptor antagonist, were ineffective. The joint application of atropine and SR140333 produced no additive effect. Atropine reduced NK(1) -induced contraction. Transcripts encoding RAS components were detected in the colon samples. However, just AT(1A) mRNA was expressed in both preparations, and AT(2) mRNA was expressed only in the distal colon. CONCLUSION: In the murine colon, local RAS may play a significant role in the control of contractile activity. Ang II positively modulates the spontaneous contractile activity via activation of post-junctional and pre-junctional AT(1A) receptors, the latter located on the enteric neurones, modulating the release of tachykinins and acetylcholine.


Subject(s)
Angiotensin II/metabolism , Colon/metabolism , Muscle Contraction/physiology , Muscle, Smooth/metabolism , Receptor, Angiotensin, Type 1/metabolism , Angiotensin II/pharmacology , Animals , Colon/drug effects , Electrophysiology , Male , Mice , Mice, Inbred C57BL , Muscarinic Antagonists/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Organ Culture Techniques , Renin-Angiotensin System/physiology , Reverse Transcriptase Polymerase Chain Reaction
4.
Br J Pharmacol ; 164(6): 1580-9, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21615720

ABSTRACT

BACKGROUND AND PURPOSE: Adenosine is considered to be an important modulator of intestinal motility. This study was undertaken to investigate the role of adenosine in the modulation of contractility in the mouse duodenum and to characterize the adenosine receptor subtypes involved. EXPERIMENTAL APPROACH: RT-PCR was used to investigate the expression of mRNA encoding for A(1), A(2A), A(2B) and A(3) receptors. Contractile activity was examined in vitro as changes in isometric tension. KEY RESULTS: In mouse duodenum, all four classes of adenosine receptors were expressed, with the A(2B) receptor subtype being confined to the mucosal layer. Adenosine caused relaxation of mouse longitudinal duodenal muscle; this was antagonized by the A(1) receptor antagonist and mimicked by N(6) -cyclopentyladenosine (CPA), selective A(1) agonist. The relaxation induced by A(1) receptor activation was insensitive to tetrodotoxin (TTX) or N(ω) -nitro-l-arginine methyl ester (l-NAME). Adenosine also inhibited cholinergic contractions evoked by neural stimulation, effect reversed by the A(1) receptor antagonist, but not myogenic contractions induced by carbachol. CPA and 2-p-(2-carboxyethyl) phenethylamino-5'-N-ethylcarboxamidoadenosine hydrochloride hydrate (CGS-21680), A(2A) receptor agonist, both inhibited the nerve-evoked cholinergic contractions. l-NAME prevented only the CGS-21680-induced effects. S-(4-Nitrobenzyl)-6-thioinosine, a nucleoside uptake inhibitor, reduced the amplitude of nerve-evoked cholinergic contractions, an effect reversed by an A(2A) receptor antagonist or l-NAME. CONCLUSIONS AND IMPLICATIONS: Adenosine can negatively regulate mouse duodenal motility either by activating A(1) inhibitory receptors located post-junctionally or controlling neurotransmitter release via A(1) or A(2A) receptors. Both receptors are available for pharmacological recruitment, even if only A(2A) receptors appear to be preferentially stimulated by endogenous adenosine.


Subject(s)
Adenosine/physiology , Duodenum/physiology , Gastrointestinal Motility , Receptors, Purinergic P1/physiology , Adenosine/pharmacology , Animals , Duodenum/drug effects , Electric Stimulation , Gastrointestinal Motility/drug effects , In Vitro Techniques , Isometric Contraction/drug effects , Male , Mice , Mice, Inbred C57BL , Nucleoside Transport Proteins/antagonists & inhibitors , Purinergic Antagonists/pharmacology , Purinergic P1 Receptor Agonists/pharmacology , RNA, Messenger/metabolism , Thioinosine/analogs & derivatives , Thioinosine/pharmacology
5.
J Agric Food Chem ; 58(13): 7565-71, 2010 Jul 14.
Article in English | MEDLINE | ID: mdl-20518499

ABSTRACT

We investigated, using an organ bath technique, the effects of a hydrophilic extract from Opuntia ficus indica fruit pulp (cactus fruit extract, CFE) on the motility of mouse ileum, and researched the extract component(s) responsible for the observed responses. CFE (10-320 mg of fresh fruit pulp equivalents/mL of organ bath) reduced dose-dependently the spontaneous contractions. This effect was unaffected by tetrodotoxin, a neuronal blocker, N(omega)-nitro-l-arginine methyl ester, a nitric oxide synthase blocker, tetraethylammonium, a potassium channel blocker, or atropine, a muscarinic receptor antagonist. CFE also reduced the contractions evoked by carbachol, without affecting the contractions evoked by high extracellular potassium. Indicaxanthin, but not ascorbic acid, assayed at concentrations comparable with their content in CFE, mimicked the CFE effects. The data show that CFE is able to exert direct antispasmodic effects on the intestinal motility. The CFE inhibitory effects do not involve potassium channels or voltage-dependent calcium channels but rather pathways of calcium intracellular release. The fruit pigment indicaxanthin appears to be the main component responsible for the CFE-induced effects.


Subject(s)
Betaxanthins/pharmacology , Ileum/drug effects , Opuntia/chemistry , Plant Extracts/pharmacology , Pyridines/pharmacology , Animals , Fruit/chemistry , Gastrointestinal Motility/drug effects , Ileum/physiology , Male , Mice , Mice, Inbred C57BL
6.
Neurogastroenterol Motil ; 22(6): 664-e203, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20158614

ABSTRACT

BACKGROUND: Glucagon-like peptide-1 (GLP-1) is a proglucagon-derived peptide expressed in the enteroendocrine-L cells of small and large intestine and released in response to meal ingestion. Glucagon-like peptide-1 exerts inhibitory effects on gastrointestinal motility through vagal afferents and central nervous mechanisms; however, no data is available about a direct influence on the gastrointestinal wall. Our aim was to investigate the effects of GLP-1 on the spontaneous and evoked mechanical activity of mouse duodenum and colon and to identify the presence and distribution of GLP-1 receptors (GLP-1R) in the muscle coat. METHODS: Organ bath recording technique and immunohistochemistry were used. KEY RESULTS: Glucagon-like peptide-1 (up to the concentration of 1 mumol L(-1)) failed to affect spontaneous mechanical activity. It caused concentration-dependent reduction of the electrically evoked cholinergic contractions in circular smooth muscle of both intestinal segments, without affecting the longitudinal muscle responses. Glucagon-like peptide-1 inhibitory effect was significantly antagonized by exendin (9-39), an antagonist of GLP-1R. In both intestinal preparations, GLP-1 effect was not affected by guanethidine, a blocker of adrenergic neurotransmission, but it was significantly reduced by N(omega)-nitro-l-arginine methyl ester, inhibitor of nitric oxide (NO) synthase. Glucagon-like peptide-1 failed to affect the contractions evoked by exogenous carbachol. Immunohistochemistry demonstrated GLP-1R expression in the enteric neurons. Furthermore, 27% of GLP-1R immunoreactive (IR) neurons in the duodenum and 79% of GLP-1R-IR neurons in the colon, co-expressed nNOS. CONCLUSIONS & INFERENCES: The present results suggest that GLP-1 is able to act in the enteric nervous system by decreasing the excitatory cholinergic neurotransmission through presynaptic GLP-1Rs, which modulate NO release.


Subject(s)
Enteric Nervous System/drug effects , Glucagon-Like Peptide 1/pharmacology , Motor Neurons/drug effects , Neurons/drug effects , Peripheral Nervous System/drug effects , Receptors, Glucagon/drug effects , Acetylcholinesterase/metabolism , Animals , Enteric Nervous System/cytology , Enzyme Inhibitors/pharmacology , Gastrointestinal Motility/drug effects , Glucagon-Like Peptide 1/antagonists & inhibitors , Glucagon-Like Peptide-1 Receptor , Guanethidine/pharmacology , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Nitric Oxide Synthase Type I/antagonists & inhibitors , Nitric Oxide Synthase Type I/metabolism , Nitroarginine/pharmacology , Peptide Fragments/pharmacology , Peripheral Nervous System/cytology , Sympatholytics/pharmacology
7.
Br J Pharmacol ; 158(1): 243-51, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19466981

ABSTRACT

BACKGROUND AND PURPOSE: Although it is well accepted that cannabinoids modulate intestinal motility by reducing cholinergic neurotransmission mediated by CB(1) receptors, it is not known whether the endocannabinoids are involved in more complex circuits and if they interact with other systems. The aim of the present study was to examine possible interactions between cannabinoid CB(1) receptors and purines in the control of spontaneous contractility of longitudinal muscle in mouse ileum. EXPERIMENTAL APPROACH: The mechanical activity of longitudinally oriented ileal segments from mice was recorded as isometric contractions. KEY RESULTS: The selective CB(1) receptor agonist, N-(2-chloroethyl)5,8,11,14-eicosaetraenamide (ACEA) reduced, concentration dependently, spontaneous contractions in mouse ileum. This effect was almost abolished by tetrodotoxin (TTX) or atropine. Inhibition by ACEA was not affected by theophylline (P1 receptor antagonist) or by P2Y receptor desensitization with adenosine 5'[beta-thio]diphosphate trilithium salt, but was significantly reversed by pyridoxal phosphate-6-azo(benzene-2,4-disulphonic acid) (P2 receptor antagonist), by P2X receptor desensitization with alpha,beta-methyleneadenosine 5'-triphosphate lithium salt (alpha,beta-MeATP) or by 8,8'-[carbonylbis(imino-4,1-phenylenecarbonylimino-4,1-phenylenecarbonylimino) bis(1,3,5-naphthalenetrisulphonic acid)] (P2X receptor antagonist). Contractile responses to alpha,beta-MeATP (P2X receptor agonist) were virtually abolished by TTX or atropine, suggesting that they were mediated by acetylcholine released from neurones, and significantly reduced by ACEA. CONCLUSION AND IMPLICATIONS: In mouse ileum, activation of CB(1) receptors, apart from reducing acetylcholine release from cholinergic nerves, was able to modulate negatively, endogenous purinergic effects, mediated by P2X receptors, on cholinergic neurons. Our study provides evidence for a role of cannabinoids in the modulation of interneuronal purinergic transmission.


Subject(s)
Adenosine Triphosphate/metabolism , Gastrointestinal Motility/physiology , Ileum/physiology , Receptor, Cannabinoid, CB1/metabolism , Animals , Arachidonic Acids/pharmacology , Biomechanical Phenomena/drug effects , Biomechanical Phenomena/physiology , Dose-Response Relationship, Drug , Gastrointestinal Motility/drug effects , Ileum/drug effects , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Protein Binding/physiology , Receptor, Cannabinoid, CB1/agonists
8.
Neuroscience ; 150(3): 658-64, 2007 Dec 12.
Article in English | MEDLINE | ID: mdl-17997228

ABSTRACT

Using conventional microelectrode recording techniques, we investigated, in the circular muscle of the mouse caecum, the neurotransmitter(s) involved in the neurally-evoked inhibitory junction potentials (IJPs) and the existence of possible prejunctional mechanisms controlling neurotransmitter release. Electrical field stimulation with single pulses elicited IJPs, consisting only of a "fast" hyperpolarization, while using train stimuli (30-50 Hz) the initial fast hyperpolarization was followed by a slower hyperpolarization. The fast and the slow component were selectively antagonized by apamin, a blocker of calcium-activated potassium channels, and N(omega)-nitro-l-arginine methyl ester (l-NAME), a nitric oxide synthase inhibitor, respectively. Fast IJPs were antagonized also by P2 purinoceptor antagonists, suramin or 4-[[4-formyl-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]-2-pyridinyl]azo]-1,3-benzenedisulfonic acid tetrasodium salt (PPADS), P2Y purinoceptor desensitization by adenosine 5'-O-2-thiodiphosphate (ADPbetaS). 2'-Deoxy-N(6)-methyl ADP diammonium salt (MRS 2179), P2Y1 purinoceptor antagonist, at the concentration of 1 microM increased the amplitude of the fast IJP, while at the concentration of 10 microM induced a reduction. 8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino (4-fluoro-3,1-phenylene) carbonylimino]] bis-1,3,5-naphthalenetrisulfonic acid hexasodium salt (NF 157) and 2,2-dimethyl-propionic acid 3-(2-chloro-6-methylaminopurin-9-yl)-2-(2,2-dimethyl-propionyl-oxymethyl)-propyl ester (MRS 2395), P2Y11 and P2Y12 purinoceptor antagonist, were without any effect. ATP-induced hyperpolarization was affected by apamin and by P2Y purinoceptor desensitization, but not by MRS 2179. 2-(Methylthio)ATP tetrasodium salt hydrate (2-MeSATP), P2Y1 purinoceptor agonist, at a concentration which did not cause changes in the membrane potential, reduced the amplitude of the fast IJPs. This effect was prevented by MRS 2179. Paired nerve stimulation, either using single pulses or train stimuli, did not cause any alteration of the second-evoked IJP. In conclusion, in the circular muscle of the mouse caecum, ATP is responsible for the fast IJP while nitric oxide is responsible for the slow IJP. ATP-mediated response is dependent on ADPbetaS-sensitive P2Y receptors, which are in part P2Y1, but not P2Y11 or P2Y12 receptor subtypes. In addition, the most substantial finding of this study is the functional demonstration that ATP released by nerve stimulation activates P2Y1 receptors, located prejunctionally, limiting its release by motoneurons.


Subject(s)
Cecum/innervation , Enteric Nervous System/physiology , Receptors, Purinergic P2/physiology , Synaptic Transmission/physiology , Adenosine Triphosphate/metabolism , Animals , Antineoplastic Agents/pharmacology , Apamin/pharmacology , Cecum/physiology , Electric Stimulation , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/physiology , Mice , Mice, Inbred C57BL , Nitric Oxide/metabolism , Purinergic P2 Receptor Antagonists , Receptors, Purinergic P2Y1 , Receptors, Purinergic P2Y12 , Suramin/pharmacology
9.
Br J Pharmacol ; 151(1): 73-81, 2007 May.
Article in English | MEDLINE | ID: mdl-17351663

ABSTRACT

BACKGROUND AND PURPOSE: This study analysed the contribution of the purinergic system to enteric neurotransmission in the longitudinal muscle of mouse distal colon. EXPERIMENTAL APPROACH: Motor responses to exogenous ATP and to nerve stimulation in vitro were assessed as changes in isometric tension. KEY RESULTS: ATP induced a concentration-dependent contraction, reduced by 4-[[4-formyl-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]-2-pyridinyl]azo]-1,3-benzene disulphonic acid (PPADS), suramin, P2Y purinoreceptor desensitisation with adenosine 5'-O-2-thiodiphosphate (ADPbetaS), and atropine, but unaffected by P2X purinoceptor desensitisation with alpha,beta-methylene ATP (alpha,beta-meATP) and by 2,2-dimethyl-propionic acid 3-(2-chloro-6-methylaminopurin-9-yl)-2-(2,2-dimethyl-propionyloxymethyl)-propyl ester (MRS 2395), a P2Y(12) selective antagonist. The response to ATP was increased by 2'-deoxy-N(6)-methyl adenosine 3',5'-diphosphate (MRS 2179), a P2Y(1) selective antagonist, tetrodotoxin (TTX) or N(omega)-nitro-L-arginine methyl ester (L-NAME). ADPbetaS, a P2Y-purinergic agonist, induced muscular contraction, with the same pharmacological profile as the ATP-induced contraction. ADP, a natural ligand for P2Y(1) receptors, induced muscular relaxation, antagonized by MRS 2179 and by TTX or L-NAME. Nerve stimulation elicited a transient nitrergic relaxation, followed by contraction. Contractile responses was reduced by atropine, PPADS, suramin, P2Y purinoceptor desensitisation, but not by P2X purinoceptor desensitisation, MRS 2179 or MRS 2395. None of the purinergic antagonists modified the nerve-evoked relaxation. CONCLUSIONS AND IMPLICATIONS: In the longitudinal muscle of mouse distal colon, ATP, through ADPbetaS-sensitive P2Y purinoceptors, contributed to the excitatory neurotransmission acting directly on smooth muscle and indirectly via activation of cholinergic neurons. Moreover, P2Y1 purinoceptors appear to be located on nitrergic inhibitory neurons. This study provides new insights into the role of purines in the mechanism inducing intestinal transit in mouse colon.


Subject(s)
Adenosine Triphosphate/pharmacology , Colon/drug effects , Muscle Contraction/drug effects , Neurotransmitter Agents/pharmacology , Purinergic Agonists , Adenine/analogs & derivatives , Adenine/pharmacology , Adenosine Diphosphate/analogs & derivatives , Adenosine Diphosphate/pharmacology , Animals , Colon/physiology , Dose-Response Relationship, Drug , Electric Stimulation , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Pyridoxal Phosphate/analogs & derivatives , Pyridoxal Phosphate/pharmacology , Thionucleotides/pharmacology , Valerates/pharmacology
10.
Neurogastroenterol Motil ; 18(9): 844-52, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16918764

ABSTRACT

This study investigated whether alterations in gastric activity in dystrophic mdx mouse can be attributed to dysfunctions of tachykinins. Endoluminal pressure was recorded and the expression of neuronal nitric oxide synthase (nNOS), NK1 and NK2 neurokinin receptors was investigated by immunohistochemistry. SR48968, NK2 receptor antagonist, but not SR140333, NK1 receptor antagonist, decreased the tone only in mdx gastric preparations. In the presence of N(omega)-nitro-l-arginine methyl ester (l-NAME), inhibitor of NOS, SR48968 reduced the tone also in normal stomach. [Sar(9), Met(O(2))(11)]-SP, agonist of NK1 receptors, caused tetrodotoxin-sensitive relaxations, antagonized by SR140333 or l-NAME, with no difference in the potency or efficacy between normal and mdx preparations. [beta-Ala(8)]-NKA(4-10), an NK2 receptor agonist, induced SR48968-sensitive contractions in both types of preparations, although the maximal response of mdx tissues was significantly lower than normal preparations. Immunohistochemistry demonstrated a consistent reduction of nNOS and NK2 receptor expression in mdx stomach smooth muscle cells and no change in nNOS and NK1 receptor expression in neurones. In conclusion, in mdx stomach the activation of NK2 receptors plays a role in the development of the tone, associated with a reduced NO production by muscular nNOS. The hypo-responsiveness to NK2 receptors could depend on the reduced expression of these receptors.


Subject(s)
Gastrointestinal Motility/physiology , Muscular Dystrophy, Duchenne/physiopathology , Receptors, Neurokinin-2/metabolism , Stomach/physiopathology , Tachykinins/metabolism , Animals , Benzamides/pharmacology , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Gastrointestinal Motility/drug effects , Immunohistochemistry , Male , Manometry , Mice , Mice, Inbred mdx , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle Tonus/drug effects , Muscle Tonus/physiology , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Muscular Dystrophy, Duchenne/complications , NG-Nitroarginine Methyl Ester/pharmacology , Neurokinin-1 Receptor Antagonists , Nitric Oxide Synthase Type I/biosynthesis , Organ Culture Techniques , Piperidines/pharmacology , Quinuclidines/pharmacology , Receptors, Neurokinin-1/metabolism , Receptors, Neurokinin-2/antagonists & inhibitors , Stomach/drug effects
11.
Neurogastroenterol Motil ; 15(5): 559-65, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14507355

ABSTRACT

The present study was undertaken to analyse duodenal contractility in adult dystrophic (mdx) mice. The spontaneous changes of the isometric tension and the responses of longitudinal duodenal muscle to nonadrenergic, noncholinergic (NANC) nerve stimulation and to exogenous drugs were compared between normal and mdx mice. Duodenal segments from mdx mice displayed spontaneous contractions with higher frequency than normals. N omega-nitro-L-arginine methyl ester (L-NAME) increased the frequency of contractions in normals without affecting that in mdx mice. In normals, NANC nerve stimulation elicited a transient relaxation abolished by L-NAME. In mdx mice a frank relaxation was not observed, the inhibitory response consisted just in the suppression of the phasic activity. This response was reduced by L-NAME and abolished by the subsequent addition of alpha-chymotrypsin. In normals, alpha-chymotrypsin hardly affected NANC relaxation, whilst it significantly antagonised that in mdx mice. Mdx duodenal muscle also showed a reduced responsiveness to sodium nitroprusside, and to 8-bromoguanosine 3', 5'-cyclic monophosphate in comparison with normal preparations. The results indicate that mdx mice experience duodenal contractile disturbances due to an impairment of NO function with defective responsiveness of the muscle to NO. The reduction in NO influence is functionally compensated by the peptidergic system.


Subject(s)
Duodenum/metabolism , Gastrointestinal Motility/physiology , Muscle Contraction/physiology , Nitric Oxide/metabolism , Animals , Dose-Response Relationship, Drug , Duodenum/drug effects , Dystrophin/genetics , Dystrophin/metabolism , Gastrointestinal Motility/drug effects , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Mice, Inbred mdx , Muscle Contraction/drug effects , Nitric Oxide/antagonists & inhibitors
12.
Neurogastroenterol Motil ; 14(6): 667-75, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12464089

ABSTRACT

This study examined whether alterations of the spontaneous and evoked mechanical activity are present in the stomach of the mdx mouse, the animal model for Duchenne muscular dystrophy. The gastric mechanical activity from whole-organ of normal and mdx mice was recorded in vitro as changes of intraluminal pressure. All gastric preparations developed spontaneous tone and phasic contractions, although the tone of the mdx preparations was significantly greater. Atropine reduced the tone of the two preparations by the same degree. Nomega-nitro-l-arginine methyl ester (l-NAME) significantly increased the tone and spontaneous contractions only in the stomach from normal animals, but did not affect on the mdx preparations. Effects ofl-NAME on tone and contractility were preserved in the presence of tetrodotoxin. In both types of tissues electrical field stimulation (EFS) induced a biphasic response: cholinergic contraction followed by slow relaxation. In nonadrenergic noncholinergic conditions, EFS induced a rapid relaxation followed by a slow component in both types of tissues. l-NAME abolished the rapid component, reduced the slow component and unmasked tachychinergic contractions. No significant difference was found in evoked responses. The enteric neurotransmission is preserved in mdx gastric preparations, although alterations in the ongoing production of nitric oxide are present.


Subject(s)
Muscle Contraction/physiology , Muscle, Smooth/physiology , Muscular Dystrophy, Animal/physiopathology , Nitric Oxide/metabolism , Stomach/physiology , Anesthetics, Local/pharmacology , Animals , Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Electric Stimulation , Enzyme Inhibitors/pharmacology , Male , Mice , Mice, Inbred mdx , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Muscular Dystrophy, Duchenne/physiopathology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Donors/pharmacology , Nitroprusside/pharmacology , Organ Culture Techniques , Stomach/drug effects , Tetrodotoxin/pharmacology
13.
Am J Physiol Gastrointest Liver Physiol ; 281(5): G1264-70, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11668035

ABSTRACT

The aim of the present study was to evaluate whether alterations in the distribution and/or function of nitric oxide synthase (NOS) could be involved in the development of the spontaneous mechanical tone observed in colon from dystrophic (mdx) mice. By recording the intraluminal pressure of isolated colon from normal mice, we showed that N(omega)-nitro- L-arginine methyl ester (L-NAME) increased the tone, even in the presence of tetrodotoxin. The effect was prevented by L-arginine, nifedipine, or Ca(2+)-free solution. In colon from mdx mice, L-NAME was ineffective. Immunohistochemistry revealed that the presence and distribution of neuronal (nNOS), endothelial, and inducible NOS isoforms in smooth muscle cells and neurons of colon from mdx mice were the same as in controls. However, the expression of myogenic nNOS was markedly reduced in mdx mice. We conclude that there is a myogenic NOS in mouse colon that can tonically produce nitric oxide to limit influx of Ca(2+) through L-type voltage-dependent channels and modulate the mechanical tone. This mechanism appears to be defective in mdx mice.


Subject(s)
Colon/metabolism , Muscle, Smooth/metabolism , Muscular Dystrophy, Duchenne/metabolism , Nitric Oxide Synthase/biosynthesis , Nitric Oxide/biosynthesis , Animals , Colon/pathology , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Mice, Inbred mdx , Muscle, Smooth/pathology , Muscular Dystrophy, Duchenne/pathology , Reference Values
14.
Gastroenterology ; 120(6): 1430-7, 2001 May.
Article in English | MEDLINE | ID: mdl-11313313

ABSTRACT

BACKGROUND & AIMS: Proximal colon from dystrophic mice develops spontaneous tone increment, but the mechanisms involved in its development have not been investigated. This study examined whether alterations in the properties of cell membrane calcium channels and/or sarcoplasmic reticular (SR) Ca2+-adenosine triphosphatase (ATPase) contribute to tone development. METHODS: Effects of calcium-free solution, nifedipine, pinaverium (calcium channel blockers), and cyclopiazonic acid (CPA; SR Ca2+-ATPase inhibitor) on the contractile activity of colon from mdx and control mice were determined. RESULTS: Calcium-free solution abolished spontaneous contractions in both preparations, but decreased the tone only in mdx mice. Nifedipine or pinaverium abolished phasic contractions, acting with different sensitivities on the 2 preparations. They also decreased the tone in colons of mdx mice, and Ca2+-free solution did not cause any further loss of tone. CPA, after an early contractile effect, abolished spontaneous contractions in control animals. It did not suppress the contractile activity in mdx mice. CPA inhibited the repletion of intracellular calcium stores in both tissues to the same degree. CONCLUSIONS: Increased Ca2+ influx through L-type voltage-dependent Ca2+ channels seems to be responsible for the sustained mechanical tone of proximal colon from mdx mice. The mechanisms for sequestering calcium appear to be unaltered.


Subject(s)
Calcium/metabolism , Colon/physiopathology , Muscle Contraction , Muscular Dystrophies/physiopathology , Animals , Indoles/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred mdx , Muscle Contraction/drug effects , Nifedipine/pharmacology
15.
Neurogastroenterol Motil ; 13(2): 169-75, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11298996

ABSTRACT

Because the colon from dystrophic (mdx) mice shows an altered motor pattern, probably due to neural disorders, our aim was to examine the electrophysiological properties of muscle cells and the functionality of nitrergic transmission in circular muscle from normal and mdx colon. Normal colonic cells (resting membrane potential [RMP] about -50 mV) showed spontaneous hyperpolarizations (inhibitory junction potentials; IJPs) and cyclic slow depolarizations were sometimes recorded. Mdx colon had a depolarized RMP (about -36 mV) and spontaneous IJPs, but the cyclic activity was never observed. In the normal colon, Nomega-nitro-L-arginine methyl ester (L-NAME) induced depolarization and abolished the cyclic activity. In the mdx colon, L-NAME caused a slight depolarization. Both preparations displayed the same value of RMP in the presence of L-NAME. In normals, neural stimulation induced nonadrenergic, noncholinergic IJPs composed of fast hyperpolarizations followed by a nitrergic slow hyperpolarization, selectively abolished by L-NAME. In the mdx colon the evoked IJPs were composed only of the initial fast hyperpolarization, the nitrergic component being absent. The hyperpolarization to sodium nitroprusside was not significantly different in both preparations. We conclude that the colon from animals lacking in dystrophin displays different electrophysiological features because of an impairment of nitric oxide function.


Subject(s)
Colon/physiopathology , Muscle, Smooth/physiopathology , Muscular Dystrophy, Animal/physiopathology , Animals , Colon/innervation , Colon/metabolism , Electric Stimulation , Electrophysiology , Enzyme Inhibitors/pharmacology , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mice, Inbred C57BL , Mice, Inbred mdx , Muscle, Smooth/innervation , Muscle, Smooth/metabolism , Muscular Dystrophy, Duchenne/physiopathology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/metabolism , Synaptic Transmission/physiology
16.
Neurogastroenterol Motil ; 12(5): 459-66, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11012946

ABSTRACT

The role of endogenous tachykinins and the mechanisms whereby they act on NK2 receptors, modulating spontaneous motility, were investigated in rat isolated proximal colon. The mechanical activity was detected as changes in intraluminal pressure. The NK2 receptor antagonist, MEN 10627, produced a concentration-dependent reduction of the contraction amplitude. [beta-Ala8]-neurokinin A(4-10), an NK2 receptor agonist, and [Sar9, Met(O2)11]-Substance P ([Sar9, Met(O2)11]-SP), an NK1 receptor agonist, induced a concentration-dependent contractile response, characterized by an increase in basal tone with superimposed phasic contractions. MEN 10627 antagonized the response to [beta-Ala8]-neurokinin A(4-10), without affecting that to [Sar9, Met(O2)11]-SP. Tetrodotoxin (TTX), hexamethonium and Nomega-nitro-L-arginine methyl ester (L-NAME) significantly reduced the response to MEN 10627. The NK3 receptor agonist, senktide, was able to activate the nitrergic inhibitory pathway, as it induced a TTX-and L-NAME-sensitive inhibitory effect. [beta-Ala8]-neurokinin A(4-10) was able to antagonize the inhibitory response to senktide. These findings suggest that tachykinins acting on NK2 receptors play a role in the modulation of the spontaneous mechanical activity. The mechanism of this action would be, in part, acting directly on the smooth muscle cells, and, in part neurogenic, sustained by nicotinic inputs, and possibly due to inhibition of NO tonic release.


Subject(s)
Colon/drug effects , Gastrointestinal Motility/drug effects , Neurokinin A/pharmacology , Peptides, Cyclic/pharmacology , Receptors, Neurokinin-2/drug effects , Animals , Benzamides/pharmacology , Colon/physiology , Enzyme Inhibitors/pharmacology , Gastrointestinal Motility/physiology , Male , NG-Nitroarginine Methyl Ester/pharmacology , Neurokinin A/physiology , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/metabolism , Piperidines/pharmacology , Rats , Rats, Wistar , Receptors, Neurokinin-2/physiology
17.
Br J Pharmacol ; 127(2): 514-20, 1999 May.
Article in English | MEDLINE | ID: mdl-10385253

ABSTRACT

1. The cellular mechanisms by which endogenous nitric oxide (NO) modulates spontaneous motility were investigated in rat isolated proximal colon. The mechanical activity was detected as changes in intraluminal pressure. 2. Apamin (1-100 nM) produced a concentration-dependent increase in the amplitude of the spontaneous pressure waves. The maximal contractile effect was of the same degree as that produced by Nomega-nitro-L-arginine methyl ester (L-NAME) (100 microM) and the joint application of apamin plus L-NAME had no additive effects. Apamin (0.1 microM) reduced the inhibitory effects (i.e. reduction in the amplitude of the pressure waves) induced by sodium nitroprusside (SNP) (1 nM - 10 microM) or 8-Br-cyclic GMP (1-100 microM). 3. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (0.1-5 microM), inhibitor of NO-stimulated guanylate cyclase, produced a concentration-dependent increase of the spontaneous contractions. ODQ (1 microM) in the presence of apamin (0.1 microM) did not produce any further increase in the contraction amplitude, whereas after L-NAME (100 microM) it decreased the spontaneous contractions. ODQ (1 microM) reduced the SNP inhibitory effects. 4. Zaprinast (1-50 microM), inhibitor of cyclic GMP phosphodiesterase, produced a concentration-dependent decrease of the spontaneous contractions. The effects of zaprinast were significantly reduced in the presence of apamin (0.1 microM) or L-NAME (100 microM). 5. These results suggest that small conductance Ca2+-dependent K+ channels and cyclic GMP are involved in the modulation of the spontaneous contractile activity in rat proximal colon. Cyclic GMP production system and opening of apamin-sensitive K+ channels appear to work sequentially in transducing an endogenous NO signal.


Subject(s)
Colon/drug effects , Cyclic GMP/physiology , Muscle, Smooth/drug effects , Nitric Oxide/pharmacology , Potassium Channels/physiology , 3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Animals , Enzyme Inhibitors/pharmacology , Guanylate Cyclase/antagonists & inhibitors , In Vitro Techniques , Male , Muscle Contraction/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitroprusside/pharmacology , Oxadiazoles/pharmacology , Phosphodiesterase Inhibitors/pharmacology , Potassium Channels/drug effects , Purinones/pharmacology , Quinoxalines/pharmacology , Rats , Rats, Wistar
18.
J Auton Pharmacol ; 19(1): 1-6, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10385264

ABSTRACT

1. In order to examine the role of nitric oxide (NO) in the tonic neural inhibition in rat proximal colon, the effects of N(omega)-nitro-L-arginine methyl ester (L-NAME) were studied on the spontaneous contractions of circular muscle (monitored as intraluminal pressure changes) and of longitudinal muscle (detected as isometric tension changes). 2. L-NAME (3 x 10(-6)-3 x 10(-4) M) caused a concentration-dependent increase in the amplitude of circular contractions, without affecting those of longitudinal muscle. This effect was prevented by L-arginine (1-5 x 10(-3) M), but not D-arginine. 3. In the presence of tetrodotoxin (10(-6) M), which per se induced increase of the pressure waves, L-NAME (10(-4) M) caused no further effects on the amplitude of the spontaneous contractions. 4. The response to L-NAME (10(-4) M) was unaffected by atropine (10(-6) M), guanethidine (10(-6) M), hexamethonium (up to 3 x 10(-4) M) or alpha-chymotrypsin (up to 5 U ml(-1)). 5. NK2 receptor antagonists, SR 48968 (3 x 10(-6) M) or MEN 10627 (10(-6) M), produced a reduction of the amplitude of the pressure waves but failed to affect the contractile response to L-NAME (10(-4) M). 6. These findings suggest that tonic production of NO from inhibitory neurones influences the degree of contractions of circular muscle. An involvement of an inhibitory peptide as well as disinhibition of cholinergic or NK2-tachykinergic excitatory neurotransmission in the mechanism of NO action can be ruled out.


Subject(s)
Colon/drug effects , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/pharmacology , Animals , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Inhibitors/pharmacology , In Vitro Techniques , Isometric Contraction/drug effects , Male , Rats , Rats, Wistar
19.
Neurogastroenterol Motil ; 11(2): 133-9, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10320594

ABSTRACT

The aim of this study was to compare the motor pattern (recorded as changes in intraluminal pressure) of isolated duodenum and proximal colon between dystrophic mdx and normal mice. When duodenal recordings from control preparations were compared with mdx mice there was no significant difference in the spontaneous motor pattern, responses to electrical nerve stimulation or sensitivity to pharmacological agents. Colonic segments from mdx mice showed a more complex motor pattern, consisting of contractions with amplitude and frequency similar to those of controls and by additional contractions with lower amplitude and higher frequency. Moreover, 70% of the colonic preparations from mdx mice developed active tone. TTX (1 microM), both in control and in mdx mice, changed the motor pattern, revealing regular rhythmic contractions similar in both preparations. L-NAME (100 microM) in both preparations increased contractile activity, revealing additional low contractions in control and potentiating them in mdx colon. In both control and mdx mice, inhibitory responses elicited by electrical field stimulation (EFS) were significantly attenuated by L-NAME. Our results provide evidence for the presence of a different motor pattern in mdx proximal colon and suggest that mdx mice can be considered a suitable animal model for investigating the dystrophic process.


Subject(s)
Gastrointestinal Motility/physiology , Intestine, Large/physiology , Intestine, Small/physiology , Muscular Dystrophy, Animal/physiopathology , Animals , Biomechanical Phenomena , Colon/physiology , Duodenum/physiology , Electric Stimulation , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Mice, Inbred mdx , Reference Values
20.
J Auton Pharmacol ; 18(1): 21-9, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9728322

ABSTRACT

1. Electrical field stimulation (EFS) of muscle strips in vitro elicited a tetrodotoxin (TTX)-sensitive biphasic contractile response consisting of a phasic component followed by a tonic one. 2. The amplitude of both components of the response was impaired by N omega-nitro-L-arginine and potentiated by sodium nitroprusside. Cystamine caused a reduction in amplitude of both phasic and tonic components of the response to EFS. Neither N omega-nitro-L-arginine, sodium nitroprusside, nor cystamine induced changes in the resting muscle tone, or in the contractile response to exogenous agonists ATP and noradrenaline (NA). 3. The nitric oxide scavenger, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, induced a reduction in amplitude of both components of the response to EFS. 4. These results reveal a facilitatory prejunctional modulatory role for nitric oxide in sympathetic neurotransmission in rat vas deferens. Endogenous nitric oxide released in the extracellular space is presumed to potentiate neurotransmission by acting at prejunctional level via cGMP.


Subject(s)
Nitric Oxide/metabolism , Sympathetic Nervous System/metabolism , Vas Deferens/metabolism , Animals , Cyclic N-Oxides/pharmacology , Cystamine/pharmacology , Electric Stimulation , Enzyme Inhibitors/pharmacology , Guanylate Cyclase/antagonists & inhibitors , Imidazoles/pharmacology , Male , Muscle Contraction/drug effects , Nitric Oxide Synthase/antagonists & inhibitors , Nitroarginine/pharmacology , Nitroprusside/pharmacology , Rats , Rats, Wistar , Sympathetic Nervous System/drug effects , Vas Deferens/drug effects , Vas Deferens/innervation
SELECTION OF CITATIONS
SEARCH DETAIL
...